June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
retina-VAE: Variationally Decoding the Spectrum of Macular Disease
Author Affiliations & Notes
  • Stephen Gbejule Odaibo
    Artificial Intelligence, RETINA-AI Health, Inc, Houston, Texas, United States
  • Footnotes
    Commercial Relationships   Stephen Odaibo, RETINA-AI Health, Inc (I), RETINA-AI Health, Inc (E), RETINA-AI Health, Inc (P)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 1829. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Stephen Gbejule Odaibo; retina-VAE: Variationally Decoding the Spectrum of Macular Disease. Invest. Ophthalmol. Vis. Sci. 2020;61(7):1829.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : In this paper, we seek a clinically-relevant latent code for representing the spectrum of macular disease.

Methods : Towards this end, we construct retina-VAE, a variational autoencoder-based model that accepts a patient profile vector (pVec) as input. The pVec components include clinical exam findings and demographic information. We evaluate the model on a subspectrum of the retinal maculopathies, in particular, exudative age-related macular degeneration, central serous chorioretinopathy, and polypoidal choroidal vasculopathy. For these three maculopathies, a database of 3000 6-dimensional pVecs (1000 each) was synthetically generated based on known disease statistics in the literature. The database was then used to train the VAE and generate latent vector representations. Kmeans was then used only to identify members of each cluster and to inspect cluster properties.

Results : We found training performance to be best for a 3-dimensional latent vector architecture compared to 2 or 4 dimensional latents. Additionally, for the 3D latent architecture, we discovered that the resulting latent vectors were strongly clustered spontaneously into one of 14 clusters.

Conclusions : These clusters suggest underlying disease subtypes which may potentially respond better or worse to particular pharmaceutical treatments such as anti-vascular endothelial growth factor variants. The retina-VAE framework will potentially yield new fundamental insights into the mechanisms and manifestations of disease. And will potentially facilitate the development of personalized pharmaceuticals and gene therapies.

This is a 2020 ARVO Annual Meeting abstract.

 

Composite latent vector map

Composite latent vector map

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×